Kalbe Farma Tbk PT KLBF.JK · IDR

Health Care · IDX · 🇮🇩 Indonesia

Compare

740

-1.99%

Close of 9 Nov 2026, in IDR

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

At a glance

Figures in IDR, from our data supplier.

FY2025

Revenue

IDR 35.32trn

FY2016FY2025

Net income

IDR 3.66trn

FY2016FY2025

Free cash flow

IDR 2.46trn

FY2016FY2025

Shareholders' equity

IDR 23.31trn

FY2016FY2025

Income statement

Fiscal years

	FY2025	FY2024	FY2023	FY2022	FY2021	FY2020	FY2019	FY2018	FY2017	FY2016
Revenue	IDR 35.32trn	IDR 32.63trn	IDR 30.45trn	IDR 28.93trn	IDR 26.26trn	IDR 23.11trn	IDR 22.63trn	IDR 21.07trn	IDR 20.18trn	IDR 19.37trn
Gross profit	IDR 14.06trn	IDR 12.96trn	IDR 11.55trn	IDR 11.70trn	IDR 11.28trn	IDR 10.25trn	IDR 10.24trn	IDR 9.85trn	IDR 9.81trn	IDR 9.49trn
Research and development	IDR 499.71bn	IDR 471.60bn	IDR 627.26bn	IDR 288.34bn	IDR 532.79bn	IDR 483.76bn	IDR 543.46bn	IDR 352.03bn	IDR 494.17bn	IDR 461.80bn
Operating income	IDR 4.55trn	IDR 4.07trn	IDR 3.63trn	IDR 4.49trn	IDR 4.16trn	IDR 3.64trn	IDR 3.42trn	IDR 3.29trn	IDR 3.24trn	IDR 3.11trn
Net income	IDR 3.66trn	IDR 3.24trn	IDR 2.77trn	IDR 3.38trn	IDR 3.18trn	IDR 2.73trn	IDR 2.51trn	IDR 2.46trn	IDR 2.40trn	IDR 2.30trn
Diluted earnings per share	80.51	70.52	59.81	73.12	136,624.38	58.31	53.48	52.42	51.28	49.06

Balance sheet

At each fiscal year end

	FY2025	FY2024	FY2023	FY2022	FY2021	FY2020	FY2019	FY2018	FY2017	FY2016
Total assets	IDR 30.70trn	IDR 29.43trn	IDR 27.06trn	IDR 27.24trn	IDR 25.67trn	IDR 22.56trn	IDR 20.26trn	IDR 18.15trn	IDR 16.62trn	IDR 15.23trn
Cash and short-term investments	IDR 4.49trn	IDR 4.87trn	IDR 3.40trn	IDR 4.10trn	IDR 6.48trn	IDR 5.40trn	IDR 3.24trn	IDR 3.33trn	IDR 2.97trn	IDR 3.07trn
Total liabilities	IDR 5.97trn	IDR 4.84trn	IDR 3.94trn	IDR 5.14trn	IDR 4.40trn	IDR 4.29trn	IDR 3.56trn	IDR 2.85trn	IDR 2.72trn	IDR 2.76trn
Debt	IDR 297.94bn	IDR 561.59bn	IDR 621.63bn	IDR 1.17trn	IDR 626.16bn	IDR 1.16trn	IDR 816.85bn	IDR 357.41bn	IDR 318.99bn	IDR 283.11bn
Shareholders' equity	IDR 23.31trn	IDR 24.59trn	IDR 23.12trn	IDR 22.10trn	IDR 21.27trn	IDR 18.28trn	IDR 16.71trn	IDR 15.29trn	IDR 13.89trn	IDR 12.46trn
Shares outstanding	45,524m	45,951m	46,256m	46,256m	23m	46,873m	46,873m	46,875m	46,875m	46,875m

Cash flow

Fiscal years

	FY2025	FY2024	FY2023	FY2022	FY2021	FY2020	FY2019	FY2018	FY2017	FY2016
Cash from operations	IDR 3.27trn	IDR 4.79trn	IDR 2.91trn	IDR 3.77trn	IDR 2.83trn	IDR 4.21trn	IDR 2.50trn	IDR 2.77trn	IDR 2.01trn	IDR 2.16trn
Capital spending	−IDR 809.87bn	−IDR 1.25trn	−IDR 1.18trn	−IDR 870.10bn	−IDR 1.00trn	−IDR 1.12trn	−IDR 1.98trn	−IDR 1.37trn	−IDR 1.24trn	−IDR 1.10trn
Free cash flow	IDR 2.46trn	IDR 3.53trn	IDR 1.73trn	IDR 2.90trn	IDR 1.83trn	IDR 3.10trn	IDR 520.04bn	IDR 1.40trn	IDR 772.83bn	IDR 1.06trn
Dividends paid	−IDR 1.64trn	−IDR 1.43trn	−IDR 1.76trn	−IDR 1.63trn	−IDR 1.31trn	−IDR 1.22trn	−IDR 1.22trn	−IDR 1.17trn	−IDR 1.03trn	−IDR 890.63bn

Latest quarters

By quarter end

	Jun 2026	Mar 2026	Dec 2025	Sept 2025	Jun 2025	Mar 2025	Dec 2024	Sept 2024
Revenue	IDR 9.80trn	IDR 9.68trn	IDR 9.34trn	IDR 8.91trn	IDR 8.23trn	IDR 8.85trn	IDR 8.39trn	IDR 7.91trn
Gross profit	IDR 3.52trn	IDR 3.60trn	IDR 3.64trn	IDR 3.39trn	IDR 3.35trn	IDR 3.68trn	IDR 3.44trn	IDR 2.94trn
Operating income	IDR 1.16trn	IDR 1.31trn	IDR 1.28trn	IDR 809.66bn	IDR 1.05trn	IDR 1.38trn	IDR 1.08trn	IDR 694.08bn
Net income	IDR 890.54bn	IDR 1.03trn	IDR 1.03trn	IDR 656.41bn	IDR 898.17bn	IDR 1.08trn	IDR 862.26bn	IDR 573.28bn
Diluted earnings per share	19.68	22.74	22.71	14.42	19.73	23.65	18.76	12.48
Cash from operations	IDR 1.05trn	IDR 282.15bn	IDR 1.09trn	IDR 897.93bn	IDR 956.75bn	IDR 344.56bn	IDR 1.26trn	IDR 1.19trn
Capital spending	−IDR 239.83bn	−IDR 156.96bn	−IDR 257.73bn	−IDR 220.23bn	−IDR 149.01bn	−IDR 143.13bn	−IDR 235.45bn	−IDR 262.72bn
Free cash flow	IDR 814.96bn	IDR 125.19bn	IDR 836.45bn	IDR 677.71bn	IDR 807.74bn	IDR 201.44bn	IDR 1.02trn	IDR 923.74bn
Total assets	IDR 33.08trn	IDR 31.99trn	IDR 30.70trn	IDR 30.10trn	IDR 29.51trn	IDR 30.58trn	IDR 29.43trn	IDR 28.75trn
Cash and short-term investments	IDR 4.99trn	IDR 4.55trn	IDR 4.49trn	IDR 4.20trn	IDR 3.95trn	IDR 4.69trn	IDR 4.87trn	IDR 4.32trn
Debt	IDR 805.64bn	IDR 279.14bn	IDR 297.94bn	IDR 521.34bn	IDR 781.10bn	IDR 533.07bn	IDR 560.78bn	IDR 742.73bn
Shareholders' equity	IDR 24.33trn	IDR 24.30trn	IDR 23.31trn	IDR 22.98trn	IDR 24.19trn	IDR 25.36trn	IDR 24.59trn	IDR 23.91trn

Financial ratios

Data as of 26 Aug 2026

	FY2025	FY2024	FY2023	FY2022	FY2021	FY2020
Gross margin	39.8%	39.7%	37.9%	40.5%	43.0%	44.3%
Operating margin	12.9%	12.5%	11.9%	15.5%	15.8%	15.7%
Net margin	10.4%	9.9%	9.1%	11.7%	12.1%	11.8%
Return on equity	15.7%	13.2%	12.0%	15.3%	15.0%	15.0%
Return on assets	11.9%	11.0%	10.2%	12.4%	12.4%	12.1%
Free cash flow yield	11.0%	16.1%	10.8%	12.3%	20150.5%	14.0%
Revenue growth	8.3%	7.2%	5.2%	10.2%	13.6%	2.1%
Earnings growth	13.1%	17.1%	-18.2%	6.2%	16.5%	9.0%
Current ratio	3.47x	4.11x	4.91x	3.77x	4.45x	4.12x
Debt to equity	0.01x	0.02x	0.03x	0.05x	0.03x	0.06x
Equity ratio	75.9%	83.6%	85.4%	81.1%	82.9%	81.0%
Interest coverage	128.95x	58.75x	38.18x	81.59x	72.51x	40.60x
R&D as a share of sales	1.4%	1.4%	2.1%	1.0%	2.0%	2.1%
Buybacks as a share of market value	0.9%	0.7%	0.0%	-198405.0%	100.0%	0.0%

Growth per year

Compound annual rate

	3 years	5 years	10 years
Revenue	6.9%	8.9%	7.0%
Operating income	0.4%	4.6%	5.3%
Net income	2.7%	6.0%	6.2%

Average margins

Over each period

	1 year	3 years	5 years	10 years
Gross margin	39.8%	39.5%	40.6%	43.1%
Operating margin	12.7%	13.1%	13.9%	14.5%
Net margin	10.2%	10.3%	10.7%	11.0%

Valuation history

At each fiscal year end

	FY2025	FY2024	FY2023	FY2022	FY2021	FY2020	FY2019	FY2018	FY2017	FY2016
Price to earnings	15.0	19.3	26.9	28.6	0.0	25.4	30.3	29.0	33.0	30.9
Price to sales	1.6	1.9	2.5	3.3	—	3.0	3.4	3.4	3.9	3.7

Dividends and splits

Per share, in the currency the company pays

Paid for 3 years. Last went ex-dividend on 4 Jun 2026.

	FY2026	FY2025	FY2024	FY2023	FY2021	FY2020	FY2019	FY2018
Paid in the year	20.00	36.00	31.00	38.00	28.00	26.00	26.00	25.00

5-for-1 split · 8 Oct 2012
2-for-1 split · 2 Jan 2004
1.88-for-1 split · 13 Nov 2000
5-for-1 split · 27 Sept 1999
2-for-1 split · 7 Oct 1996
2-for-1 split · 8 Jun 1994

Sources and methodology

Data on this tab: Our data supplier
Chart on the Overview: TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.

Asset classes

Countries / Regions

Market tools

News & insights

Kalbe Farma Tbk PT KLBF.JK · IDR

Search any instrument

At a glance

Income statement

Balance sheet

Cash flow

Latest quarters

Financial ratios

Growth per year

Average margins

Valuation history

Dividends and splits

Sources and methodology